1. Introduction {#sec1}
===============

DNA-damage is induced by ionizing radiation, genotoxic chemicals, or collapsed replication forks, and when DNA was damaged or the responses of cells were failure, the mutation associated with the breast or ovarian cancer of genes may occur. To prevent and repair the DNA-damage, mammalian cells will control and stabilize the genome by cell cycle checkpoint. The checkpoint pathway consists of several kinases, such as ataxia telangiectasia mutated protein (ATM \[[@B1], [@B2]\]), ataxia telangiectasia and Rad3-related protein (ATR \[[@B1], [@B2]\]), checkpoint kinase 1 (Chk1 \[[@B3], [@B4]\]), and checkpoint kinase 2 (Chk2 \[[@B5]--[@B8]\]). ATM and ATR are upstream kinases passing messages to downstream kinases and phosphorylating several proteins that initiate the activation of the DNA-damage checkpoint. Moreover, ATM is a primarily pathway to activate p53 (protein 53 \[[@B9]\]) by Chk2, and ATR may influence the phosphorylation of Chk1. Both Chk1 and Chk2 are key components in DNA-damage; however, their cellular activities are different. Chk1 is involved in S and G2 phases of the cell cycle with ATR pathway. By contrast, Chk2 is activated in all phases through ATM-dependent pathway and plays an important role in response to DNA double-strand breaks and related lesions. Furthermore, Chk1 is an unstable protein and lacks the forkhead-associated domain (FHA) which was involved in several processes that protect against cancer and can be found in Chk2. Therefore, we concentrate on Chk2 in this study.

Chk2 is a protein containing 543 amino acid residues and the structure of Chk2 consists of some functional elements, including the N-terminal SQ/TQ cluster domain (SCD), FHA, and the N-terminal serine/threonine kinase domain (KD) \[[@B5]--[@B8]\]. The SCD is known to be the preferred site with the residue Thr68 for phosphorylation to respond to DNA-damage by ATM/ATP kinases. The FHA domain is a phosphopeptide recognition domain found in many regulatory proteins and thought to bind to the phosphoThr68 segment of SCD \[[@B5]--[@B8], [@B10]--[@B14]\]. Hence it is a good candidate for interactions of Chk2 with its upstream regulators or downstream targets in the cell-cycle-checkpoint signaling. The KD occupies almost the entire carboxy-terminal half of Chk2 and has been identified based on their homology with serine/threonine kinases. Some studies reported that when DNA was damaged, Chk2 is activated by ATM/ATR through the phosphorylation of residue Thr68. Moreover, Chk2 induces transautophosphorylation of residues Thr383 and Thr387 and then cis-phosphorylation of residue Ser516 \[[@B5]--[@B8], [@B10]--[@B14]\]. After that, Chk2 will phosphorylate several downstream substrates, such as BRCA1 (breast cancer 1, early onset \[[@B15], [@B16]\]), Cdc25A (cell division cycle 25 homolog A), Cdc25C, and p53 \[[@B7], [@B8], [@B10]\]. Several researches indicated that Chk2 phosphorylates Cdc25A which is considered an oncogene on the residue Ser123 in S phase of cell cycle, and it also phosphorylates Cdc25C on the residue Ser216 in G2 phase helping prevent mitotic entry in cells with damaged DNA \[[@B5]\]. Furthermore, BRCA1 and p53 are involved in DNA repair process in the breast or ovarian cancer. BRCA1 is a human caretaker gene and helps repair damaged DNA or destroys cells which cannot be repaired. The p53 is a tumor suppressor protein involved in preventing cancer in human and plays an important role in the G1 checkpoint in response to DNA damaging agents. We consider that the sites of the phosphorylations are important in the drug design for cell survival when DNA is damaged.

Recently, several studies identified the inhibitors of Chk2 \[[@B6]--[@B8], [@B10]--[@B14]\], and they also showed the crystal structures of Chk2 complex, such as PDB: 1GXC, 2W7X, and, and so forth. They are selective, reversible, and ATP-competitive Chk2 inhibitors demonstrating that they effectively restrain the radiation-induced phosphorylation of Chk2. In addition, several selective Chk2 inhibitors have been also identified (two examples were shown in [Figure 1](#fig1){ref-type="fig"}) and the researches indicated that they are potential and selective inhibitors of Chk2 with chemotherapeutic and radiosensitization potential. On structure-based drug design, several developments of Chk2 were published \[[@B17], [@B18]\]. Quantitative structure-activity relationship model (QSAR model) is a regression or classification model and is an important technique in the rational drug design. It is used to correlate the structure properties of compounds with their biological activities. The method to predict the quality by QSAR was improved by considering the three-dimensional structure QSAR (3D-QSAR) \[[@B19]--[@B24]\] of targeted inhibitor. Therefore, the compound structure can be directly optimized in the 3D space. The comparative molecular field analyses (CoMFA) \[[@B18], [@B25]--[@B30]\] and the comparative molecular similarity indices analyses (CoMSIA) \[[@B18], [@B27]--[@B32]\] for Chk2 inhibitors were performed by ligand-based and receptor-guided alignment. They used the cocrystal structure from protein data bank (PDB code: 2CN8) \[[@B7]\], and then they identified new plausible binding modes used as template for 3D-QSAR \[[@B18]\]. There is another research of Chk2 studied in QSAR/QSPR \[[@B17]\] providing structures that will improve reducing the side effects of Chk2 inhibitors.

Pharmacophore \[[@B20]--[@B24], [@B33]--[@B35]\] is a set of structural features responsible for the biological activity of a molecule. It allowed compounds with diverse structures to find the common chemical features by ligand pharmacophore mapping, and that is different from CoMFA and CoMSIA with the common structure constraint. Thus, pharmacophore can explain how diverse ligands bind to a receptor site by these features and visualize the feature of potential chemical interactions between ligands and receptors. Moreover, pharmacophore can easily and quickly identify candidate inhibitors for a target protein based on 3D query. Therefore, in this work, we first used 3D-QSAR study to build pharmacophore hypotheses (denoted as PhModels) for Chk2 inhibitors by HypoGen Best, Fast, and Caesar algorithms, respectively. Then we used the combinatorial fusion to select and combine prediction results for improving the predictive accuracy in biological activities of inhibitors. Virtual screening is a computational technique used in drug discovery research. There are two categories of screening techniques: ligand-based and structure-based. In this work, for ligand-based virtual screening, we used the selected PhModels as 3D structure query by pharmacophore hypothesis screening that each compound in National Cancer Institute (NCI) database will be mapped onto the pharmacophoric features of selected PhModels. When the chemical features of a compound fit the generated PhModels, it will be selected. All of feasible compounds in NCI database were selected in this work. Finally, the potential inhibitors were retrieved from selected compounds by using molecular docking program to predict the conformation and interaction energy between Chk2 and ligand. Applying combinatorial fusion into PhModels and virtual screening techniques is a novel design strategy for drug design and can help medicinal chemists to identify or design new Chk2 inhibitors. Besides, the potential inhibitors of Chk2 retrieved in this work can be estimated by biologists for further study.

2. Materials and Methods {#sec2}
========================

2.1. Biological Data Collection {#sec2.1}
-------------------------------

In order to construct the PhModels, at first, we collected the Chk2 inhibitors with two-dimensional structures and the biological activity values from the ChEMBL database \[[@B36]\]. Then, according to the structure variations and chemical differences in the kinase inhibitor activity, 158 known Chk2 inhibitors were selected and retrieved. The biological activity of 158 known Chk2 inhibitors was represented as IC~50~ (nanomolar, nM). There are 260,071 compounds from the NCI database (release version 3, <http://cactus.nci.nih.gov/download/nci/>) which were used in the database screening and molecular docking approach in this work.

2.2. Training and Testing Sets Selection {#sec2.2}
----------------------------------------

Before generating PhModels, we should divide the 158 Chk2 inhibitors into the training set and testing set, respectively. The rules used to select training set inhibitors are according to the following requirements as suggested by the Accelrys Discovery Studio. (1) All selected inhibitors should have clear and concise information including structure features and activity range. (2) At a minimum, 16 diverse inhibitors for training set were selected to ensure the statistical significance. (3) The training set should contain the most and the least active inhibitors. (4) The biological activities of the inhibitors spanned at least 4 orders of magnitude. Based on the above four rules, the 158 Chk2 inhibitors were divided, and the scatter diagram of training set and testing set inhibitors was shown in [Figure 2](#fig2){ref-type="fig"}. [Figure 2](#fig2){ref-type="fig"} demonstrates the distribution of the inhibitors in the training set and testing set, and the representative points of the testing set are close to those of the training set. The training set with 25 inhibitors is used to construct PhModels, and the IC~50~ values of these 25 inhibitors are ranged from 2.3 to 100,000 nM ([Table 1](#tab1){ref-type="table"}). The testing set with remaining 133 inhibitors is used to test the predictive ability of generated PhModels, and the IC~50~ values of the 133 testing set inhibitors are ranged from 3.4 to 74,000 nM ([Table 2](#tab2){ref-type="table"}). After selecting the training set and testing set inhibitors, we established PhModels at first, and then we used the correlation analysis to estimate the prediction abilities of PhModels.

2.3. Pharmacophore Generation {#sec2.3}
-----------------------------

The workflow of PhModel generation for Chk2 inhibitors was shown in [Figure 3](#fig3){ref-type="fig"}. In this study, we used the HypoGen program \[[@B37]\] in Accelrys Discovery Studio 2.1 to generate PhModels. At the initial step, 3D conformations of the training set inhibitors were generated by using "3D-QSAR Pharmacophore Generation protocol" with the Best, Fast, and Caesar generating algorithms, respectively, based on the CHARMm-like force field. The conformational-space energy was constrained ≤20 kcal/mol which represented the maximum allowed energy above the global minimum energy. For each training set inhibitor, the number of the diverse 3D conformations was set to ≤255. All other parameters were set as default values. Following the above rules, the 3D conformations were generated, and then we can construct the PhModel by using "Ligand Pharmacophore Mapping protocol." Each of the ten PhModels using HypoGen Best, Fast, and Caesar algorithms were generated in this study.

2.4. Combinatorial Fusion {#sec2.4}
-------------------------

In this study, we use a combinatorial fusion technique to facilitate prediction results selection and combination for improving predictive accuracy in biological activities of inhibitors. The combinatorial fusion we take is analogous to that used in information retrieval \[[@B38], [@B39]\], pattern recognition \[[@B40]\], molecular similarity searching and structure-based screening \[[@B41]\], and microarray gene expression analysis \[[@B42]\]. These works have demonstrated the following remark \[[@B43]\].

Remark 1For a set of multiple scoring systems, each with a score function and a rank function, we have that (a) the combination of multiple scoring systems would improve the prediction accuracy only if (1) each of the systems has a relatively high performance, and (2) the individual systems are distinctive (or diversified), and (b) rank combination performs better than score combination under certain conditions.

Given an inhibitor and for each prediction result *A*, let *s* ~*A*~ be a function as the predicted biological activity and it is represented as a real number. We view the function *s* ~*A*~ as the score function. Since *s* ~*A*~ only assigns a number not a set of numbers, in this work, no rank function would be used for an inhibitor. Therefore, the rank combination and the rule (b) in [Remark 1](#rem1){ref-type="statement"} are not considered in the study. Suppose we have *m* prediction results (*m* scoring functions). There are combinatorially 2^*m*^ − 1 combinations for all *m* individual prediction results $({{\sum_{k = 1}^{m}\begin{pmatrix}
m \\
k \\
\end{pmatrix}} = 2^{m} - 1})$ with score functions. The total number of combinations to be considered for predicting biological activity of an inhibitor is 2^*m*^ − 1. This number of combinations can become huge when the number of prediction results *m* is large. Moreover, we have to evaluate the predictive power of each combination across all inhibitors. This study would start with combining only two prediction results which still retain fairly good prediction power.

Suppose *m* prediction results *A* ~*i*~, *i* = 1,2,..., *m*, are given with score function *s* ~*Ai*~; there are several different ways of combination. Among others, there are score combination, voting, linear average combination, and weighted combination \[[@B38]--[@B42]\]. Voting is computationally simple and better than simple linear combinations when applied to the situation with large number of prediction results. However, a better alternative is to reduce the number of prediction results to a smaller number and then these prediction results are combined. In this paper, we reduce the set of prediction results to those which perform relatively well and then use the rank/score function to decide whether to combine by score. In this paper, we use the rules (a) (1) and (a) (2) stated in [Remark 1](#rem1){ref-type="statement"} as our guiding principle to select prediction results and to decide on the method of combination. After generating each of the ten PhModels by using HypoGen Best, Fast, and Caesar algorithms for training set inhibitors, each of the best PhModel (denoted as Best~train~, Fast~train~, and Casear~train~) was evaluated by its correlation coefficient of the training set (*r* ~train~). Then these best PhModels were used to predict the biological activities of testing set inhibitors by using HypoGen Best, Fast, and Caesar algorithms. Therefore, there are nine prediction results (denoted as *Z* ~train~ × *Z* ~test~, *Z* = {Best, Fast, Caesar}, that is, Best~train~Best~test~) generated for testing set inhibitors. Using data fusion, results from various prediction results are combined to obtain predictions with larger accuracy rate. The diversity rank/score function is used to select the most suitable prediction results for combination. If these three best PhModels were selected, there are nine prediction results and then there are 2^9^ − 1 = 511 combinations. According to the rule (a) (1) in [Remark 1](#rem1){ref-type="statement"}, the *r* ~train~ of Casear~train~ is far less than those of Best~train~ and Fast~train~ ([Table 1](#tab1){ref-type="table"}); then, the Casear~train~ was not considered in the combinations. Therefore, there are six prediction results (*Z* ~1train~ × *Z* ~2test~, *Z* ~1~ = {Best, Fast} and *Z* ~2~ = {Best, Fast, Caesar}) and 2^6^ − 1 = 63 combinations. A special diversity rank/score graph was used to choose the best discriminating prediction results for further combination.

For an inhibitor *p* ~*i*~ in the testing set *P* = {*p* ~1~, *p* ~2~,..., *p* ~*t*~} and the pair of prediction results *A* and *B*, the diversity score function *d* ~*i*~(*A*, *B*) is defined as *d* ~*i*~(*A*, *B*) = ∑\|*s* ~*A*~ − *s* ~*B*~\|. When there are *q* prediction results selected (in this study, *q* = 6), there are $\begin{pmatrix}
q \\
2 \\
\end{pmatrix} = {{q(q - 1)}/2}$ (in this study, the number is 15) diversity score functions. If we let *i* vary and fix the prediction result pair (*A*, *B*), then *d* ~*i*~(*A*, *B*) is the diversity score function *s* ~(*A*,*B*)~ from *P* = {*p* ~1~, *p* ~2~,..., *p* ~*t*~}. Sorting *s* ~(*A*,*B*)~ into descending order would lead to the diversity rank function *r* ~(*A*,*B*)~. Consequently, the diversity rank/score function *f* ~(*A*,*B*)~ is defined as *f* ~(*A*,*B*)~ = (*s* ~(*A*,*B*)~∘*r* ~(*A*,*B*)~ ^−1^)(*j*) = *s* ~(*A*,*B*)~(*r* ~(*A*,*B*)~ ^−1^(*j*)), where *j* is in *T* = {1, 2, 3,..., *t*}. We note that the set *T* is different from the set *P* which is the testing set considered. The set *T* is used as the index set for the diversity rank function value and \|*T*\| = *t* is indeed the cardinality of *P*. The diversity rank/score function *f* ~(*A*,*B*)~ so defined exhibits the diversity trend of the prediction result pair (*A*, *B*) across the whole spectrum of input set of *t* inhibitors and is independent of the specific inhibitor under study. For two prediction results *A* and *B*, the graph of the diversity rank/score function*f* ~(*A*,*B*)~(*j*) is called the diversity rank/score graph. This study aims to examine all the *q*(*q* − 1)/2 diversity rank/score graphs to see which pair of prediction results would give the larger diversity measurement according to the rule (a) (2) in [Remark 1](#rem1){ref-type="statement"}.

2.5. Database Screen {#sec2.5}
--------------------

After examining 15 diversity rank/score graphs, the PhModels *A* and *B* determined from the best prediction result pair were used to screen the NCI database for new Chk2 inhibitor candidates. Under the PhModel, pharmacophore hypothesis screening can be used to screen small molecule database to retrieve the compounds as potential inhibitors that fit the pharmacophoric features. In this study, the "Search 3D Database protocol" with the Best/Fast/Casear Search option in Accelrys Discovery Studio 2.1 was employed to search the NCI database with 260,071 compounds. We could filter out and select the compounds in the NCI database based on the estimated activity and chemical features of PhModel.

2.6. Molecular Docking {#sec2.6}
----------------------

After the database screening approach, the selected compounds can be further estimated according to the interaction energy between a receptor and a ligand through the molecular docking approach. In this study, selected compounds in the NCI database were docked into Chk2 active sites by CDOCKER docking program, and then their CDOCKER interaction energies were estimated. Finally, new potential candidates were retrieved from the NCI database with high interaction energy. The workflow of database screening and molecular docking approach was shown in [Figure 4](#fig4){ref-type="fig"}.

3. Results {#sec3}
==========

3.1. PhModel Generation Results {#sec3.1}
-------------------------------

Each of the ten PhModels using 25 training set inhibitors and HypoGen Best, Fast, and Caesar algorithms was generated by selecting hydrogen bond acceptor (A), hydrogen bond donor (D), and hydrophobic (H) and hydrophobic aromatic (HYAR) features. Each of the best PhModels, Best~train~, Fast~train~, and Casear~train~, was evaluated with the best *r* ~train~, and the predicted biological activities of training set inhibitors and *r* ~train~ were listed in [Table 1](#tab1){ref-type="table"}, respectively. From [Table 1](#tab1){ref-type="table"}, the Best~train~ obtained better *r* ~train~ of value 0.955 than those by Fast~train~ and Casear~train~. Moreover, the *r* ~train~ of Casear~train~ is far less than those of Best~train~ and Fast~train~. Hence, HypoGen Best algorithm was used individually to generate the PhModels for most of target genes in the past. According to rule (a) (1) in [Remark 1](#rem1){ref-type="statement"}, the Casear~train~ was not considered to be used for the prediction of testing set inhibitors.

3.2. Correlation Analysis of Testing Set Inhibitors {#sec3.2}
---------------------------------------------------

The testing set inhibitors were predicted by Best~train~ and Fast~train~ with HypoGen Best, Fast, and Caesar algorithms. Therefore, there are six prediction results, Best~train~Best~test~ (denoted as BB), Best~train~Fast~test~ (denoted as BF), Best~train~Casear~test~ (denoted as BC), Fasr~train~Best~test~ (denoted as FB), Fast~train~Fast~test~ (denoted as FF), and Fast~train~Casear~test~ (denoted as FC), for testing set inhibitors. The predicted biological activities of testing set inhibitors and *r* ~test~ by these six prediction results were listed in [Table 2](#tab2){ref-type="table"}, respectively. From [Table 2](#tab2){ref-type="table"}, for the Best~train~, the best *r* ~test~ of value 0.81 was achieved by the Best~train~Best~test~; for the Fast~train~, the best *r* ~test~ of value 0.728 was achieved by the Fast~train~Fast~test~. However, the Best~train~Best~test~ obtained the best *r* ~test~ in overall; moreover, the prediction results in the Best~train~ all outperform those in the Fast~train~.

3.3. Combinatorial Fusion Analysis {#sec3.3}
----------------------------------

Under the six prediction results, the diversity score function *d* ~*i*~(*A*, *B*) was calculated for each testing set inhibitor by a pair of prediction results (*A*, *B*). There are 15 diversity score functions *s* ~(*A*,*B*)~ that were performed at first and then these diversity score functions were sorted to become the diversity rank function *r* ~(*A*,*B*)~, respectively. Finally, 15 diversity rank/score functions *f* ~(*A*,*B*)~ were represented as diversity rank/score graphs shown in [Figure 5](#fig5){ref-type="fig"}. Among 15 diversity rank/score graphs, there are several combinations (gray color) that have less diversity scores than those by others, such as BB + BC, BB + BF, and FB + FB, shown in [Figure 5](#fig5){ref-type="fig"}. It means that these combinations may have less *r* ~test~ than those by others according to rule (a) (2) in [Remark 1](#rem1){ref-type="statement"}. In other words, several combinations, such as BB + FC (purple color), BB + FF (blue color), and BF + FF (orange color), may have larger *r* ~test~ than those by others due to larger diversity scores. For the six prediction results, all of the 63 combinations were preformed and evaluated by its *r* ~test~, respectively, as shown in [Figure 6](#fig6){ref-type="fig"}. In [Figure 6](#fig6){ref-type="fig"}, for 15 pairs of two prediction results, the combinations BB + FB, BB + FC, and BB + FF have larger *r* ~test~ than those by others. Moreover, the combination BB + FF has best *r* ~test~ of value 0.816 among 15 combinations, even for 63 combinations. Besides, the average *r* ~test~ by the combinations is larger than the individual prediction results. It means that the predictive accuracy for Chk2 inhibitors may be improved by considering the Best~train~ and Fast~train~ concurrently.

3.4. Database Screen Results {#sec3.4}
----------------------------

The best PhModels, Best~train~ and Fast~train~, were used to screen the NCI database with 260,071 compounds for new Chk2 inhibitor candidates by using HypoGen Best and Fast algorithms, respectively. The Best~train~Best~test~ and Fast~train~Fast~test~ prediction results for NCI database were combined in order to filter out possible false positive candidates. Of the 260,071 compounds, 191,505 passed the screening and best fitted to the chemical features in 3D space. 23 drug-like compounds that had an estimated IC~50~ value of less than 2 nM were studied in a molecular docking study ([Figure 4](#fig4){ref-type="fig"}).

3.5. Molecular Docking Results {#sec3.5}
------------------------------

23 drug-like compounds along with the training set compounds were docked into the active sites that were defined based on the bound inhibitor, PV1019, in a crystal structure of Chk2 (PDB: 2W7X). We used CDOCKER program to confirm that inhibitor candidates bind to the receptor. CDOCKER uses molecular dynamics (MD) in conjunction with the CHARMm force field to individually dock the compounds into the binding sites. The coordinates of Chk2 from the Chk2/PV1019 crystal structure were used after removing PV1019 and solvent molecules and adding protein hydrogen atoms. After docking each screened compound, its interaction energy value was calculated. The PV1019 was redocked into the Chk2 binding site by the CDOCKER program. Its-CDOCKER interaction energy was calculated by CDOCKER and determined to be 37.786 (kal/mol). The 23 drug-like compounds were docked into the Chk2 binding sites. Finally, there are 21 drug-like compounds with CDOCKER interaction energies greater than 37.786 (kal/mol). In addition, 11 drug-like compounds had high interaction value greater than 50 (kal/mol) ([Figure 4](#fig4){ref-type="fig"}) and the top 2 are NSC136954 with 61.239 (kal/mol) and NSC70804 with 58.967 (kal/mol), respectively, kept for future characterization as inhibitors. The 21 drug-like compounds with their estimated IC~50~ values and CDOCKER interaction energy greater than 37.786 (kal/mol) were shown in [Table 3](#tab3){ref-type="table"}.

The structures and characteristics of the top 2 compounds are given in [Table 4](#tab4){ref-type="table"}, and we can find that some active site residues were identified from the Chk2 complex. The interaction sites of NSC136954 were Leu226, Val234, Ala247, Lys249, Ile251, Glu273, Ile274, Leu277, Ile286, Ile288, Ile299, Leu301, Leu303, Met304, Glu305, Gly306, Gly307, Glu308, Leu354, Thr367, Asp368, Phe369, and Gly370. On the other hand, the interaction sites of NSC70804 were Leu226, Leu227, Val234, Ala247, Ile248, Lys249, Ile251, Glu273, Leu277, Ile299, Leu301, Leu303, Met304, Gly307, Glu308, Glu351, Asn352, Leu354, Thr367, and Asp368. Several studies indicated that they are involved in hydrophobic interactions with Val234, Ile251, Leu354, Ile299, and the aliphatic portions of the side chains of Lys249, Thr367, and Asp368, in addition to several interactions of van der Waals or hydrophobic with Leu226, Val234, Leu303, Gly307, Leu354, and the aliphatic portions the side chains of Met304 and Glu308 \[[@B10], [@B11]\]. Furthermore, the quinazoline was sandwiched between the lipophilic side chains of Val234 and Leu354, with the side chains of Ala247, Leu301, and Leu303 also contributing to a hydrophobic surface surrounding the core and an interaction between the pyrazole and Lys249 is likely to account for the increase in Chk2 potency \[[@B12]\]. And residue Thr367 of Chk2 is a serine in Chk1. Portions of the glycine-rich P-loop in Chk2, which is located directly above the inhibitor, are disordered (residues 229--231), whereas this loop is well defined in the structure of Chk1, and Leu301 in Chk2 corresponds to the "gatekeeper" residue in many kinases, which has been found to form contacts with bound inhibitors and is poorly conserved \[[@B44]\].

4. Conclusions {#sec4}
==============

In this study, a novel design strategy for drug design was proposed to apply combinatorial fusion into PhModels and virtual screening techniques. 158 Chk2 inhibitors were divided into the training set and testing set, respectively. For 25 training set inhibitors, three best PhModels, Best~train~, Fast~train~, and Casear~train~, were generated at first, and then six prediction results for 133 testing set inhibitors were used for calculating 15 diversity rank/score functions. Finally, the combination Best~train~Best~test~ and Fast~train~Fast~test~ prediction results achieved the best *r* ~test~ of value 0.816 among 63 combinations. Through these approaches, 23 potential Chk2 inhibitors with IC~50~ value less than 2 nM and interaction energy value larger than 37.786 (kal/mol) are retrieved from NCI database. This study can help medicinal chemists to identify or design new Chk2 inhibitors. Besides, the potential inhibitors of Chk2 retrieved in this work can be estimated by biologists for further study.
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###### 

Experimental and estimated IC~50~ values of training set inhibitors.

  ---------------------------------------------------------------------------------------
  CHEMBL ID                        Experimental\   Estimated IC~50~(nM)           
                                   IC~50~ (nM)                                    
  -------------------------------- --------------- ---------------------- ------- -------
  CHEMBL195041                     2.3             15                     9.9     1129

  CHEMBL193990                     6.6             6.8                    6.2     942

  CHEMBL248935                     14              20                     20      833

  CHEMBL195320                     18              8.5                    6.2     942

  CHEMBL176164                     23              19                     23      1151

  CHEMBL250765                     37              30                     22      950

  CHEMBL362677                     47              23                     23      1153

  CHEMBL249959                     70              110                    20      1000

  CHEMBL250992                     72              47                     6.9     72

  CHEMBL251155                     110             220                    23      756

  CHEMBL588536                     270             670                    790     78578

  CHEMBL400772                     470             2200                   268     231

  CHEMBL367390                     640             2000                   2237    1028

  CHEMBL608262                     830             1200                   1456    94262

  CHEMBL401105                     900             1000                   235     20

  CHEMBL176115                     1100            970                    1044    1449

  CHEMBL253542                     1200            1100                   189     3.8

  CHEMBL592490                     1800            860                    1275    93360

  CHEMBL589090                     6700            1700                   1419    3561

  CHEMBL199299                     15000           22000                  233     1745

  CHEMBL251629                     19000           3600                   615     411

  CHEMBL259084                     28000           6800                   31827   5300

  CHEMBL251628                     37000           63000                  1360    24786

  CHEMBL438485                     50000           16000                  320     243

  CHEMBL589501                     100000          160000                 48276   96926

                                                                                  

  Correlation\                                     0.955                  0.840   0.238
  coefficient**  **(*r* ~train~)                                                  
  ---------------------------------------------------------------------------------------

###### 

Experimental and estimated IC~50~ values of testing set inhibitors.

  -----------------------------------------------------------------------------------------------------------------------------------
  CHEMBL ID                   Experimental\   Estimated IC~50~(nM)                                                        
                              IC~50~ (nM)                                                                                 
  --------------------------- --------------- ---------------------- ---------- ----------- --------- --------- --------- -----------
  CHEMBL195177                3.4             3.9                    5.2        5.1         14.8      6.2       12.3      6.2

  CHEMBL359881                4.4             12.0                   46.1       42.3        17.3      22.5      29.4      22.5

  CHEMBL179717                4.5             9.0                    42.1       43.2        14.3      21.9      29.3      21.9

  CHEMBL175553                5.5             11.2                   57.8       43.1        17.6      20.5      29.1      20.5

  CHEMBL192161                7               183.4                  74.6       36.7        258.7     253.9     291.4     253.9

  CHEMBL191969                8.2             6.4                    15.3       14.3        10.5      9.4       13.5      9.4

  CHEMBL175472                9.8             7.9                    48.4       9.9         12.4      22.5      29.1      22.5

  CHEMBL361378                12              9.9                    48.1       43.7        14.7      21.7      29.3      21.7

  CHEMBL362255                12              11.9                   55.4       42.3        15.5      22.9      29.4      22.9

  CHEMBL369254                12              70.2                   51.3       45.6        38.0      23.7      31.5      23.7

  CHEMBL364978                13              4.8                    4.9        5.1         13.5      6.5       12.3      6.5

  CHEMBL195846                14              3.9                    5.0        5.1         12.8      6.2       12.3      6.2

  CHEMBL179583                16              12.2                   48.5       43.1        13.4      23.2      28.9      23.2

  CHEMBL178972                17              15.9                   52.5       43.1        18.0      23.3      29.1      23.3

  CHEMBL250360                23              19.8                   46.8       43.7        17.6      21.7      29.4      21.7

  CHEMBL175879                24              21.6                   57.0       42.3        24.0      23.2      29.2      23.2

  CHEMBL179267                31              7.4                    63.5       42.8        20.5      21.2      29.4      21.2

  CHEMBL192022                32              20.3                   47.5       42.6        23.9      22.4      29.4      22.4

  CHEMBL250158                39              10.1                   20.4       43.7        19.1      21.5      29.3      21.5

  CHEMBL363339                41              10.1                   59.8       42.2        18.1      24.0      29.5      24.0

  CHEMBL250555                45              26.3                   48.2       42.9        24.5      22.7      29.4      22.7

  CHEMBL250359                52              3.7                    5.2        3.5         20.6      7.0       28.8      7.0

  CHEMBL251585                52              4.5                    3.0        3.1         11.9      4.9       10.7      4.9

  CHEMBL398529                53              23.0                   48.4       43.5        21.4      22.4      29.4      22.4

  CHEMBL178971                55              62.4                   44.9       43.1        41.7      22.1      29.3      22.1

  CHEMBL427879                55              13.7                   45.4       42.4        16.9      19.9      29.5      19.9

  CHEMBL250963                57              8.6                    44.1       42.9        17.8      21.5      27.2      21.5

  CHEMBL251170                60              51.3                   45.3       43.1        26.3      21.5      29.4      21.5

  CHEMBL250759                61              45.6                   47.4       43.3        36.6      23.2      29.5      23.2

  CHEMBL367263                61              19.7                   50.3       9.6         17.3      23.9      29.1      23.9

  CHEMBL250159                67              55.7                   45.3       43.1        25.7      17.2      29.4      17.2

  CHEMBL398467                70              11.4                   46.5       42.7        21.0      20.4      29.4      20.4

  CHEMBL250796                73              3.3                    3.4        4.2         14.7      6.0       14.4      6.0

  CHEMBL250957                74              36.1                   44.9       43.7        30.5      20.4      29.5      20.4

  CHEMBL206609                77              25.9                   51.0       44.0        9.6       16.3      17.8      16.3

  CHEMBL400755                78              8.8                    26.6       43.0        12.9      22.5      29.4      22.5

  CHEMBL249569                80              11.1                   48.3       43.3        17.0      22.9      28.0      22.9

  CHEMBL193397                81              9.9                    43.8       42.8        14.5      21.2      28.4      21.2

  CHEMBL438868                82              18.9                   42.0       43.1        13.1      19.0      29.3      19.0

  CHEMBL249566                86              17.6                   48.8       43.1        23.5      22.8      29.6      22.8

  CHEMBL249345                90              23.2                   47.6       43.0        20.9      20.0      25.0      20.0

  CHEMBL399146                90              29.8                   47.9       42.7        28.4      22.1      29.3      22.1

  CHEMBL602931                92              483.6                  560.1      506.8       645.9     594.0     588.2     594.0

  CHEMBL249347                95              10.1                   46.3       43.1        27.2      20.1      29.2      20.1

  CHEMBL193476                100             951.1                  914.5      925.8       2435.2    1027.4    1981.9    1027.4

  CHEMBL250361                100             14.2                   6.6        14.5        14.9      20.9      29.6      20.9

  CHEMBL248934                109             20.0                   52.5       43.3        14.0      22.4      29.4      22.4

  CHEMBL249750                110             12.7                   49.3       43.5        20.7      21.6      29.3      21.6

  CHEMBL208463                133             10.4                   46.0       41.0        968.6     2768.3    2670.7    2768.3

  CHEMBL250566                140             5.2                    17.3       26.3        18.4      20.9      29.6      20.9

  CHEMBL251256                140             936.4                  2453.5     2240.6      192.6     215.1     215.5     215.1

  CHEMBL437331                142             471.8                  521.6      450.6       64.2      222.1     60.7      222.1

  CHEMBL249541                157             23.8                   42.5       43.0        16.0      18.8      29.3      18.8

  CHEMBL249776                158             13.9                   47.2       43.7        16.7      20.9      29.4      20.9

  CHEMBL249350                174             30.6                   51.2       43.4        22.5      23.3      29.4      23.3

  CHEMBL249546                176             10.6                   47.3       42.8        17.9      21.0      29.4      21.0

  CHEMBL251364                176             21.7                   43.9       43.1        17.8      19.7      29.1      19.7

  CHEMBL399933                180             14.8                   45.0       43.5        20.8      18.9      29.4      18.9

  CHEMBL400287                180             19.3                   45.5       43.5        21.5      19.8      29.4      19.8

  CHEMBL175780                200             61.7                   47.5       42.3        36.0      21.9      29.5      21.9

  CHEMBL176326                200             935.6                  926.3      913.6       1896.0    986.2     1980.7    986.2

  CHEMBL590335                210             791.5                  721.8      807.4       616.3     639.0     644.7     639.0

  CHEMBL398561                220             575.1                  926.2      571.5       209.1     278.3     287.9     278.3

  CHEMBL249777                231             15.0                   45.7       42.5        25.5      21.7      29.4      21.7

  CHEMBL442282                233             13.9                   46.9       42.3        21.5      22.5      29.4      22.5

  CHEMBL195599                250             981.5                  908.0      925.8       2266.7    1057.6    1981.9    1057.6

  CHEMBL176015                290             54.1                   52.8       54.4        24.0      29.3      28.0      29.3

  CHEMBL251284                310             484.8                  429.7      533.7       189.6     196.8     217.4     196.8

  CHEMBL600441                310             454.6                  559.9      516.5       300.5     513.5     254.1     513.5

  CHEMBL599581                410             594.7                  496.6      509.1       506.1     252.9     299.2     252.9

  CHEMBL592784                420             462.2                  492.0      475.1       216.7     203.8     198.3     203.8

  CHEMBL1197465               580             2492.8                 8163.9     5925.9      995.1     896.8     488.9     896.8

  CHEMBL590809                600             492.4                  539.0      534.3       816.4     536.2     549.3     536.2

  CHEMBL1197456               610             2871.8                 7537.6     6733.2      615.7     4139.2    3514.6    4139.2

  CHEMBL590637                610             1251.9                 1786.7     1121.1      2379.0    1650.9    1262.3    1650.9

  CHEMBL591518                680             1797.9                 1804.0     1516.5      6075.0    4714.4    2726.5    4714.4

  CHEMBL598973                700             12585.6                151896.0   84151.4     1047.3    396.5     1318.1    396.5

  CHEMBL251368                710             27.7                   45.9       43.8        13.4      21.2      29.1      21.2

  CHEMBL1197303               800             5153.6                 36481.1    6594.4      1277.8    681.9     4077.9    681.9

  CHEMBL1197320               890             2537.8                 7191.1     6002.7      1559.4    517.5     420.0     517.5

  CHEMBL1197528               960             2752.7                 7737.1     5925.9      765.7     654.9     559.0     654.9

  CHEMBL215803                1000            3760.6                 140257.0   74847.0     9672.7    50053.5   49263.9   50053.5

  CHEMBL253324                1000            996.2                  2416.5     603.1       264.7     553.1     272.4     553.1

  CHEMBL589347                1100            458.3                  560.2      482.3       209.7     299.1     196.7     299.1

  CHEMBL604784                1100            1188.4                 1365.6     1205.7      2305.3    1962.3    1307.9    1962.3

  CHEMBL1197529               1120            2047.4                 11678.5    8090.0      3368.8    3648.8    3659.9    3648.8

  CHEMBL1197326               1130            12645.5                45428.8    7432.7      1138.2    465.0     416.0     465.0

  CHEMBL176041                1200            925.0                  906.8      913.6       1933.6    1040.0    1980.7    1040.0

  CHEMBL590079                1350            548.9                  548.5      550.6       1000.9    860.3     855.1     860.3

  CHEMBL605083                1400            489.2                  613.8      554.4       1224.9    1401.0    1345.6    1401.0

  CHEMBL175481                1500            69.2                   57.7       49.2        1853.9    1526.1    1852.1    1526.1

  CHEMBL205906                1540            1696.1                 1109.3     1153.0      980.6     17655.5   937.5     17655.5

  CHEMBL590808                1600            1662.5                 1799.1     1709.4      51882.2   48813.2   48302.3   48813.2

  CHEMBL1170748               1700            1974.2                 1940.4     1652.8      3251.4    2734.9    407.6     2734.9

  CHEMBL253541                1800            43066.9                42831.1    79622.8     1255.9    1099.1    15566.3   1099.1

  CHEMBL176554                1900            572.3                  7226.3     9126.2      1096.1    3352.6    3926.3    3352.6

  CHEMBL377597                2000            938.5                  6719.7     5644.6      50.4      116.9     105.4     116.9

  CHEMBL1170749               2200            10874.0                30873.8    3995.6      5835.1    25044.3   1090.5    25044.3

  CHEMBL590336                2200            507.8                  594.0      516.4       568.9     544.3     521.1     544.3

  CHEMBL590807                2200            52944.6                70480.3    52639.4     44898.4   49196.7   36195.2   49196.7

  CHEMBL600868                2200            1342.8                 1603.8     1312.9      7373.6    5797.7    4864.3    5797.7

  CHEMBL398759                2300            666.0                  2847.2     1010.2      447.2     924.3     309.0     924.3

  CHEMBL604459                2300            1176.9                 2299.2     1369.3      614.2     877.8     682.5     877.8

  CHEMBL179383                2400            15724.9                14621.7    14257.4     4508.5    4132.8    4023.9    4132.8

  CHEMBL592489                2400            469.2                  494.6      486.9       204.7     240.5     208.4     240.5

  CHEMBL425904                2800            605.0                  651.0      534.9       478.1     451.9     488.6     451.9

  CHEMBL150894                3000            537.8                  844.9      797.6       186.8     600.2     289.0     600.2

  CHEMBL590793                3000            475.4                  2480.4     1251.5      192.0     251.7     205.4     251.7

  CHEMBL600865                4400            796.9                  2072.3     1223.3      198.1     261.3     228.1     261.3

  CHEMBL249253                5000            659.8                  503.6      499.5       406.6     227.9     309.5     227.9

  CHEMBL587506                5200            1050.8                 1293.3     1083.2      2201.3    2162.7    1656.0    2162.7

  CHEMBL204930                5800            755.5                  1260.7     1105.5      47881.6   47912.3   47868.0   47912.3

  CHEMBL554900                5900            6722.8                 580526.0   807309.0    745.4     428.2     47897.1   428.2

  CHEMBL176276                6000            3360.2                 8955.9     8476.6      2075.6    2054.0    1970.7    2054.0

  CHEMBL589091                6100            1319.5                 1308.4     1172.0      579.2     603.1     600.9     603.1

  CHEMBL559781                7400            91783.7                822917.0   1230010.0   414.5     6865.5    47911.9   6865.5

  CHEMBL249252                8000            100671.0               38586.8    31129.8     590.5     491.6     467.9     491.6

  CHEMBL589089                9800            1070.7                 1321.5     1002.7      38589.3   48136.2   41143.2   48136.2

  CHEMBL217090                10000           628.8                  1010.9     1548.5      390.6     451.8     910.1     451.8

  CHEMBL217092                10000           1030.2                 1199.3     1908.8      379.9     625.6     707.2     625.6

  CHEMBL382588                10000           1365.2                 5880.3     5488.7      2560.7    3993.4    3649.4    3993.4

  CHEMBL590581                10000           145206.0               149922.0   108067.0    50609.5   49348.5   48302.3   49348.5

  CHEMBL242753                10300           1742.5                 3393.1     1941.1      1202.5    2613.0    1297.3    2613.0

  CHEMBL398758                11000           1582.8                 187965.0   1573.6      237.0     4333.9    369.0     4333.9

  CHEMBL399151                11000           812.1                  1263.5     2069.9      334.5     1193.9    1271.6    1193.9

  CHEMBL395080                13450           513.5                  484.0      458.6       198.5     188.9     183.3     188.9

  CHEMBL1171533               15000           349604.0               296515.0   159368.0    26784.5   26699.3   45506.4   26699.3

  CHEMBL602729                17000           148756.0               149052.0   139465.0    224.1     324.7     229.4     324.7

  CHEMBL249255                19000           182486.0               42615.8    41578.3     1698.2    616.1     683.9     616.1

  CHEMBL202930                21730           12828.4                11945.6    12145.8     213.3     219.7     217.6     219.7

  CHEMBL589986                22000           1167.1                 1337.4     1143.5      53747.5   49155.6   49316.8   49155.6

  CHEMBL251471                40000           3358.9                 1946.2     2075.7      512.2     423.7     3427.4    423.7

  CHEMBL560056                74000           152006.0               156723.0   208466.0    223.2     208.1     190.4     208.1

                                                                                                                          

  Correlation\                                0.810                  0.771      0.783       0.710     0.728     0.714     **0.816**
  coefficient  (*r* ~test~)                                                                                               
  -----------------------------------------------------------------------------------------------------------------------------------

###### 

The 21 drug-like compounds with their estimated IC~50~values and CDOCKER interaction energy greater than 37.786 (kal/mol).

  Name             Estimated IC~50~(nM)   Interaction energy (kal/mol)
  ---------------- ---------------------- ------------------------------
  **NSC 136954**   **1.989**              **61.239**
  **NSC 70804**    **1.682**              **58.967**
  NSC 158029       1.885                  57.944
  NSC 603427       1.87                   56.963
  NSC 57782        1.6855                 56.54
  NSC 16739        1.5385                 56.342
  NSC 720227       1.914                  55.839
  NSC 618702       1.862                  55.196
  NSC 195178       1.7015                 51.351
  NSC 653142       1.557                  51.19
  NSC 653143       1.577                  50.055
  NSC 32200        1.901                  49.439
  NSC 342015       1.6515                 47.327
  NSC 343685       1.7615                 46.436
  NSC 205750       1.875                  45.542
  NSC 96538        1.705                  44.344
  NSC 210455       1.7935                 42.258
  NSC 314654       1.947                  42.082
  NSC 179894       1.6135                 41.707
  NSC 91710        1.701                  40.533
  NSC 370907       1.8785                 40.502

###### 

The structures and characteristics of the top 2 compounds.

  --
  --

[^1]: Academic Editor: Che-Lun Hung
